Crossmark Global Holdings’s Acadia Healthcare ACHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,728
| Closed | -$204K | – | 1320 |
|
|
2025
Q1 | $204K | Buy |
6,728
+72
| +1% | +$2.74K | ﹤0.01% | 1268 |
|
|
2024
Q4 | $264K | Sell |
6,656
-421
| -6% | -$19K | ﹤0.01% | 1093 |
|
|
2024
Q3 | $449K | Buy |
7,077
+440
| +7% | +$31.8K | 0.01% | 911 |
|
|
2024
Q2 | $448K | Sell |
6,637
-671
| -9% | -$46.9K | 0.01% | 883 |
|
|
2024
Q1 | $579K | Sell |
7,308
-150
| -2% | -$12.3K | 0.01% | 800 |
|
|
2023
Q4 | $580K | Sell |
7,458
-235
| -3% | -$17.4K | 0.01% | 783 |
|
|
2023
Q3 | $555K | Sell |
7,693
-276
| -3% | -$20.6K | 0.01% | 774 |
|
|
2023
Q2 | $633K | Sell |
7,969
-135
| -2% | -$9.76K | 0.01% | 738 |
|
|
2023
Q1 | $586K | Buy |
8,104
+55
| +0.7% | +$4.29K | 0.01% | 757 |
|
|
2022
Q4 | $663K | Buy |
8,049
+123
| +2% | +$10.1K | 0.02% | 686 |
|
|
2022
Q3 | $619K | Sell |
7,926
-104
| -1% | -$8.31K | 0.02% | 692 |
|
|
2022
Q2 | $544K | Sell |
8,030
-320
| -4% | -$22.3K | 0.01% | 782 |
|
|
2022
Q1 | $547K | Buy |
8,350
+100
| +1% | +$5.81K | 0.01% | 864 |
|
|
2021
Q4 | $501K | Buy |
8,250
+750
| +10% | +$44.7K | 0.01% | 891 |
|
|
2021
Q3 | $478K | Sell |
7,500
-300
| -4% | -$18.9K | 0.01% | 945 |
|
|
2021
Q2 | $489K | Buy |
7,800
+280
| +4% | +$17.6K | 0.01% | 939 |
|
|
2021
Q1 | $430K | Sell |
7,520
-370
| -5% | -$20K | 0.01% | 981 |
|
|
2020
Q4 | $397K | Sell |
7,890
-2,960
| -27% | -$118K | 0.01% | 947 |
|
|
2020
Q3 | $320K | Sell |
10,850
-30
| -0.3% | -$871 | 0.01% | 983 |
|
|
2020
Q2 | $273K | Buy |
10,880
+60
| +0.6% | +$1.5K | 0.01% | 1063 |
|
|
2020
Q1 | $199K | Buy |
10,820
+20
| +0.2% | +$573 | 0.01% | 1066 |
|
|
2019
Q4 | $359K | Sell |
10,800
-1,310
| -11% | -$41K | 0.01% | 1004 |
|
|
2019
Q3 | $376K | Sell |
12,110
-350
| -3% | -$10.7K | 0.01% | 921 |
|
|
2019
Q2 | $435K | Sell |
12,460
-390
| -3% | -$12.6K | 0.01% | 875 |
|
|
2019
Q1 | $377K | Sell |
12,850
-40
| -0.3% | -$1.13K | 0.01% | 990 |
|
|
2018
Q4 | $331K | Sell |
12,890
-3,430
| -21% | -$119K | 0.01% | 1013 |
|
|
2018
Q3 | $574K | Buy |
16,320
+350
| +2% | +$13.9K | 0.01% | 870 |
|
|
2018
Q2 | $653K | Buy |
15,970
+180
| +1% | +$7.26K | 0.02% | 778 |
|
|
2018
Q1 | $619K | Sell |
15,790
-400
| -2% | -$14.7K | 0.02% | 798 |
|
|
2017
Q4 | $528K | Buy |
16,190
+6,950
| +75% | +$241K | 0.01% | 956 |
|
|
2017
Q3 | $441K | Buy |
+9,240
| New | +$450K | 0.01% | 1039 |
|
|
2016
Q3 | $441K | Buy |
+9,240
| New | +$481K | 0.01% | 1039 |
|
Other funds holding ACHC
SHCM
ABI
HRCM
Crossmark Global Holdings's ACHC Position: Q2 2025 in Review
Crossmark Global Holdings sold out of Acadia Healthcare (ACHC) in Q2 2025, closing a stake of 6,728 shares — an estimated $204K sold.
Crossmark Global Holdings first reported a position in ACHC in Q3 2016 and held it in 32 quarters. The position peaked at $663K in Q4 2022. 293 funds tracked by Wall St. Rank hold ACHC as of Q2 2025.
- Crossmark Global Holdings reported no remaining Acadia Healthcare position as of Q2 2025 after selling out during the quarter.
- Crossmark Global Holdings sold 6,728 Acadia Healthcare shares in Q2 2025, an estimated $204K.
- Crossmark Global Holdings first reported a position in Acadia Healthcare in Q3 2016 and held it in 32 quarters.
- Crossmark Global Holdings's Acadia Healthcare position peaked at $663K in Q4 2022.
- 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2025.
Based on Crossmark Global Holdings's 13F filing for Q2 2025, filed 8 Aug 2025.